Synthesis 2007(23): 3683-3691  
DOI: 10.1055/s-2007-990888
PAPER
© Georg Thieme Verlag Stuttgart · New York

Facile Regioselective Synthesis of Pyrazolo[5,1-a]isoquinolines via Ring-Opening Cyclization/Oxidation Reactions of Stable Aroyldiaziridines of 3,4-Tetrahydroisoquinoline with Alkynes

Heriberto Ortega, Sara Ahmed, Howard Alper*
Centre for Catalysis Research and Innovation, Department of Chemistry, University of Ottawa, 10 Marie Curie, Ottawa, ON, K1N 6N5, Canada
Fax: +1(613)5625871; e-Mail: howard.alper@uottawa.ca;
Further Information

Publication History

Received 16 April 2007
Publication Date:
13 November 2007 (online)

Abstract

Newly prepared, stable aroyldiaziridines of 3,4-tetrahydroisoquinolines undergo regioselective cycloaddition reactions with a number of both mono and disubstituted alkynes, affording five-membered ring products which, after oxidative aromatization of the pyrazoline ring, lead to the efficient preparation of pyrazolo[5,1-a]isoquinolines. The overall transformation is base-catalyzed and occurs more rapidly in the presence of oxygen, in halogenated solvents and in dioxane.

    References

  • 1a El Ali B. Alper H. In Transition Metal Catalyzed Reactions   Murahashi S.-I. Davies SG. Blackwell Science; Malden MA: 1999.  p.261 ; and references therein
  • 1b Katritzky AR. Rees CW. In Comprehensive Heterocyclic Chemistry   Parts 1 and 4B:  Pergamon Press; Oxford: 1984. 
  • 2a Baeg JO. Bensimon C. Alper H. J. Am. Chem. Soc.  1995,  117:  4700 
  • 2b Baeg JO. Alper H. J. Org. Chem.  1992,  57:  157 
  • 2c Maas H. Bensimon C. Alper H. J. Org. Chem.  1998,  63:  17 
  • 3a Larksarp C. Alper H. J. Am. Chem. Soc.  1997,  119:  3709 
  • 3b Larksarp C. Alper H. J. Org. Chem.  1998,  63:  6229 
  • 4 Butler DCD. Inman GA. Alper H. J. Org. Chem.  2000,  65:  5887 
  • 5 Larksarp C. Sellier O. Alper H. J. Org. Chem.  2001,  66:  3502 
  • 6 Roberto D. Alper H. J. Chem. Soc., Chem. Commun.  1987,  212 
  • 7a Cruz R. Arias ME. Soliveri J. Appl. Microbiol. Biotechnol.  2000,  53:  480 
  • 7b Cruz R. Arias MS. Arias ME. Soliveri J. J. Antibiot.  1996,  49:  419 
  • For example, as kinase inhibitors, see:
  • 8a Majid TN, Hopkins C, Pedgrift BL, Collar N, Wirtz-Brugger F, and Merrill J. inventors; WO  2005,012,301. 
  • 8b Majid TN, Hopkins C, Pedgrift BL, Collar N, Wirtz-Brugger F, and Merrill J. inventors; US  2005,009,859. 
  • 8c Flohr S, and Naumann T. inventors; WO  2004,005,287. 
  • 8d Anand NK, Blazey CM, Bowles OJ, Bussenius J, Costanzo S, Curtis JK, Dubenko L, Kennedy AR, Khoury RG, Kim AI, Manalo J.-CL, Peto CJ, Rice KD, and Tsang TH. inventors; WO  2005,009,389. As anaplastic lymphoma kinase modulators, see:
  • 8e Xu X, Clare M, Lennon P, Metz S, Vazquez M, Weier RM, and Wolfson SG. inventors; WO  2003,070,706. For the treatment of inflammation, see:
  • 8f As potential fluorescent markers for biomedical applications, see: Galunov N. Z., Krasovitskii B. M., Lyubenko O. N., Yermolenko I. G., Patsenker L. D., Doroshenko A. O.; J. Lumin.; 2003, 102-103: 119
  • 8g As anticonvulsant, see: Paronikyan EG. Sirakanyan SN. Noravyan AS. Paronikyan RG. Dzhagatspanyan IA. Pharm. Chem. J.  2001,  35:  8 
  • As plant growth regulators, see:
  • 9a Watanabe K. Kamuro Y. Taniguchi E. J. Agric. Food Chem.  1994,  42:  2311 
  • 9b Kamuro Y., Taniguchi E., Watanabe K.; EP 215,445 A2, 1987
  • 9c Watanabe K. Taniguchi E. Agric. Biol. Chem.  1986,  50:  2591 
  • As evaluated for pregnancy terminating activity in rats and hamsters, see:
  • 9d Toja E. Omodei-Sale A. Cattaneo C. Galliani G. Eur. J. Med. Chem.  1982,  17:  223 
  • 9e Omodei-Sale A, Toja E, Galliani G, and Lerner LJ. inventors; AU  516,343 B2. 
  • 10a El’natanov YI. Kostyanovskii RG. Russ. Chem. Bull.  1988,  37:  1661 ; Izv. Akad. Nauk, Ser. Khim. 1988, 1858
  • 10b Quast H. Ross KH. Spiegel E. Peters K. Von Schnering HG. Angew. Chem.  1977,  89:  202 
  • 10c Heine HW. Hoye TR. Williard PG. Hoye RC. J. Org. Chem.  1973,  38:  2984 
  • 11 Carboni B. Toupet L. Carrie R. Tetrahedron  1987,  43:  2293 
  • 12 Lehman LS. Baclawski LM. Harris SA. Heine HW. J. Org. Chem.  1981,  46:  320 
  • 13 Molchanov AP. Sipkin DI. Koptelov YB. Kopf J. Kostikov RR. Russ. J. Org. Chem.  2004,  67 ; Zh. Org. Khim. 2004, 76
  • 14 Schmitz E. Ohme R. Chem. Ber.  1962,  95:  2012 
  • 16 Schulz M. West G. J. Prakt. Chem.  1970,  312:  161 
  • 17 Tomaschewski G. Klein U. Geissler G. Tetrahedron Lett.  1980,  21:  4877 
  • For a summary of the azomethine imine reactions, see:
  • 18a Huisgen R. Proc. Chem. Soc.  1961,  357 ; and references cited therein
  • 18b Huisgen R. Grashey R. Laur P. Leitermann H. Angew. Chem.  1960,  72:  416 
  • 18c Huisgen R. Eckell A. Tetrahedron Lett.  1960,  12:  5 
  • 18d Huisgen R. Fleischmann R. Eckell A. Tetrahedron Lett.  1960,  12:  1 
  • 18e Truce WE. Allison JR. J. Org. Chem.  1975,  40:  2260 
  • 19a Lober S. Hubner H. Gmeiner P. Bioorg. Med. Chem. Lett.  1999,  9:  97 
  • 19b Tominaga Y. Ichihara Y. Mori T. Kamio Ch. Hosomi A. J. Heterocycl. Chem.  1990,  27:  263 
  • 20 Sundberg RJ. Ellis JE. J. Heterocycl. Chem.  1982,  19:  573 
  • 21 Sale AO, Toia E, Galliani G, and Lerner LJ. inventors; US  4,075,342. 
  • 22 Pelletier JC. Cava MP. J. Org. Chem.  1987,  52:  616 
15

CCDC 643312 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.